<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526314</url>
  </required_header>
  <id_info>
    <org_study_id>908270</org_study_id>
    <nct_id>NCT04526314</nct_id>
  </id_info>
  <brief_title>Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older</brief_title>
  <official_title>Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Registre des Tumeurs Digestives du Finistère</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Registre des Tumeurs Digestives du Finistère</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to assess survival trends in elderly patients with stage III&#xD;
      colon cancer&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This retrospective population-based study included patients aged 80 years and older with&#xD;
      stage III colon adenocarcinoma who underwent surgery between 2007 and 2014.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>2007-2014</time_frame>
    <description>months</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">308</enrollment>
  <condition>Colon Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>Stage 3 with adjuvant chemotherapy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Stage 3 without adjuvant chemotherapy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observational</intervention_name>
    <description>observational</description>
    <arm_group_label>Stage 3 with adjuvant chemotherapy</arm_group_label>
    <arm_group_label>Stage 3 without adjuvant chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        clinical data&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        • Stage 3 colon adenocarcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rectal tumors&#xD;
&#xD;
          -  Patients receiving neo-adjuvant chemotherapy or radiotherapy&#xD;
&#xD;
          -  Tumours of the appendix&#xD;
&#xD;
          -  Tumours with histology other than adenocarcinoma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>80 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Robaskiewicz, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Registre de tumeurs digestives du Finistère</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 15, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stage 3 colon cancer</keyword>
  <keyword>elderly</keyword>
  <keyword>survival</keyword>
  <keyword>surgery</keyword>
  <keyword>chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

